Icu Medical (ICUI) Cash & Equivalents (2009 - 2026)

Icu Medical has reported Cash & Equivalents for 18 years, with the latest figure at $288.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed 0.47% year-over-year to $288.3 million; the trailing twelve-month figure through Mar 2026 stood at $288.3 million (changed 0.47% YoY), and the FY2025 full-year result was $308.0 million, changed 0.2% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $288.3 million, down from $308.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $329.4 million in Q1 2022, with the low at $195.9 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $268.6 million across 5 years, with a median of $288.3 million in 2026.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 62.23% — and 2024, when it soared 58.48%.
• Icu Medical's Cash & Equivalents stood at $208.8 million in 2022, then climbed by 21.76% to $254.2 million in 2023, then increased by 21.38% to $308.6 million in 2024, then fell by 0.2% to $308.0 million in 2025, then declined by 6.38% to $288.3 million in 2026.
• The last three Cash & Equivalents figures came in at $288.3 million (Q1 2026), $308.0 million (Q4 2025), and $299.7 million (Q3 2025), per Business Quant data.